Series B funding round for IgGenix raising $40M in February 2023
Series B funding round for IgGenix raising $40M in February 2023
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Public | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Oleg Rogynskyy |
| Angel | Sam Altman |
| Angel | Sean Parker |
| Angel | Tony Xu |
| Angel | Eli Lilly |
| Angel | Bradley Horowitz |
| Angel | Julie Zhuo |
| Angel | Tobias Lutke |
| Angel | David Mytton |
| Angel | Young Song |
| Angel | Amjad Masad |
| Angel | Guillaume Lestrade |
| Angel | Omar El-Ayat |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$75M
Top Valuation
-
IgGenix raised $40M in a Series B round.
The round was announced on 02/01/23.
The round was led by Joel Marcus.